Unlocking the Potential: Antihistamine Use and Breast Cancer Risk in Women With Type 2 Diabetes Mellitus
AH1 use shows promise in reducing breast cancer risk in individuals with T2DM, particularly with higher dosages, warranting further research and consideration by health care practitioners.
Authors
- Szu‐Yuan Wu (ORCID: https://orcid.org/0000-0001-5637-558X)
- Ruey‐Shyang Soong (ORCID: https://orcid.org/0000-0001-7245-9505)
- Ta‐Chun Chou
- Wan‐Ming Chen (ORCID: https://orcid.org/0009-0009-6628-0635)
- Kang-Chuang Chai
- Ben Chang Shia
Institutions
- Fu Jen Catholic University (TW)
- Asia University (TW)
- Luodong Poh-Ai Hospital (TW)
- Ministry of Health and Welfare (TW)
- Wan Fang Hospital (TW)
- Taipei Medical University (TW)
Publication Details
- Journal
- Journal of the National Comprehensive Cancer Network
- Published
- 2025-02-01
- DOI
- https://doi.org/10.6004/jnccn.2024.7077
- Citations
- 2
- Primary Topic
- Mast cells and histamine
- Type
- article
- Field-Weighted Citation Impact
- 1.59